Humana Inc (HUM)
Days of sales outstanding (DSO)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | 52.27 | 56.11 | 69.09 | 30.78 | 55.48 | 56.86 | 26.53 | 27.21 | 45.79 | 43.15 | 33.00 | 35.92 | 67.80 | 65.54 | 31.53 | 33.71 | 61.45 | 74.01 | 67.17 | 30.05 | |
DSO | days | 6.98 | 6.50 | 5.28 | 11.86 | 6.58 | 6.42 | 13.76 | 13.41 | 7.97 | 8.46 | 11.06 | 10.16 | 5.38 | 5.57 | 11.58 | 10.83 | 5.94 | 4.93 | 5.43 | 12.15 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 52.27
= 6.98
To analyze Humana Inc.'s Days Sales Outstanding (DSO) over the past 8 quarters, we observe fluctuations in the collection period for accounts receivable. In Q1 2023, the DSO was notably higher at 11.86 days, indicating a slower collections process compared to the previous quarters. This could suggest potential challenges in efficiently converting credit sales into cash during that period.
However, in Q2 and Q3 2023, the DSO decreased to 5.28 days and 6.50 days, respectively, reflecting an improvement in the accounts receivable turnover and a more prompt collection of sales revenues.
Looking at Q4 2023, the DSO slightly increased to 6.98 days, but remained within a reasonable range. It could be an indication of maintaining a relatively stable collections process during that quarter.
Comparing to the same quarter in the previous year, Q4 2022 showed a DSO of 6.58 days, indicating consistency in managing accounts receivable turnover year-over-year.
Moreover, the significant increase in DSO observed in Q2 and Q3 2022 (13.76 days and 13.41 days, respectively) might have been impacted by factors like changes in credit policies or delays in collecting receivables during that period.
Overall, by monitoring the DSO trend, stakeholders can assess Humana Inc.'s efficiency in collecting outstanding receivables and manage potential liquidity risks associated with prolonged collection periods. A lower DSO typically signifies a more effective credit and collections process, whereas a higher DSO may indicate inefficiencies that require attention and optimization strategies.
Peer comparison
Dec 31, 2023
See also:
Humana Inc Average Receivable Collection Period (Quarterly Data)